ProQR Therapeutics (PRQR) Payables (2013 - 2026)
ProQR Therapeutics (PRQR) posted quarterly Payables of $215073.4 for Q1 2026, down 54.35% year-on-year from $471113.1 in Q1 2025, and down 36.58% on a QoQ basis from $339110.4 in Q4 2025.
ProQR Therapeutics (PRQR) Payables (2013 - 2026) Analysis & Trends
ProQR Therapeutics (PRQR) has reported Payables for 14 consecutive years, with $215073.4 the latest figure, recorded in Q1 2026.
- Quarterly Payables fell 54.35% year-over-year to $215073.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215073.4 (down 54.35% YoY) and the FY2025 annual result came in at $339110.4, up 1762.5% from the prior year.
- Payables fell to $215073.4 in Q1 2026 per PRQR's latest filing, from $339110.4 in the prior quarter.
- Over the last five years, Payables for PRQR reached as high as $44.6 million in Q1 2022 and fell as low as $18207.3 in Q4 2024.
- A 5-year average of $6.9 million and a median of $1.5 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables surged 233449.85% — and 2024, when it tumbled 99.11%.
- Year by year, Payables stood at $5.3 million in 2022, then sank by 66.95% to $1.8 million in 2023, then slumped by 98.96% to $18207.3 in 2024, then soared by 1762.5% to $339110.4 in 2025, then plunged by 36.58% to $215073.4 in 2026.
- According to Business Quant data, Payables over the past three periods registered $215073.4, $339110.4, and $347076.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | 215,073.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215,073.36 |
| Dec 31, 2025 | 339,110.37 |
| Sep 30, 2025 | 347,076.05 |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 471,113.07 |
| Dec 31, 2024 | 18,207.27 |
| Sep 30, 2024 | 35,276.58 |
| Jun 30, 2024 | 37,552.49 |
| Mar 31, 2024 | 376,662.86 |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 3.42 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Mar 31, 2023 | 4.76 Mn |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 5.91 Mn |
| Jun 30, 2022 | 43.86 Mn |
| Mar 31, 2022 | 44.60 Mn |
| Dec 31, 2021 | 44.96 Mn |
| Sep 30, 2021 | 20.95 Mn |
| Jun 30, 2021 | 19.63 Mn |